Eliseo J. Pérez-Stable, MD, Sunday morning’s Keynote speaker, will present “How Science Promotes Health Equity by Decreasing Disparities.” He will discuss health care disparities in minority communities and share data on the diversity of clinicians, researchers, and participants in clinical trials.

The leaders of four phase two and phase three trials will present the results of their research for the first time in a public forum on Monday at the International Conference. The Clinical Trials Symposium will highlight groundbreaking work on therapies for pulmonary hypertension, COPD, and asthma.

Shannon H. Kasperbauer, MD, and Doreen J. Addrizzo-Harris, MD, will chair the first of two joint sessions on bronchiectasis in collaboration with the American College of Chest Physicians (CHEST). Presentations will include research on identifying and diagnosing bronchiectasis, as well as therapeutics and treatments.

The ATS International Conference will recognize the 2023 Research Program Awardees at the Society’s annual Research Program Benefit on Saturday evening. Since 2004, the Research Program has awarded $22.8 million in research grants to 334 investigators.

Sumita Khatri, MD, and Gustavo Matute-Bello, MD, share their goals as new leaders of the National Heart, Lung, and Blood Institute’s Division of Lung Diseases. They also discuss the importance of the collaborative relationship between NHLBI and the ATS in helping transform research.

In this first half of a two-part series on sleep, Megan M. Lowery, MD, Jose Bernardo Contreras, MD, and Kara Lindi Dupuy-McCauley, MD, will discuss causes of sleep-disordered breathing and explore guidelines for management.